You are being redirected to the story the piece of content is found in so you can read it in context. Please click the following link if you are not automatically redirected within a couple seconds:
Drug Access: GSK Gives Consent to Canadian Drug Company To Manufacture Generic Antiretroviral for Rwanda
Author: Kaiser Network Daily HIV/AIDS Report [USA], Published on: 10 August 2007
GlaxoSmithKline on Wednesday announced that it has given consent to Toronto-based drug company Apotex to use two of its patented antiretroviral drugs...to manufacture Apo-triAvir -- a fixed-dose combination of the two drugs and the antiretroviral nevirapine -- for Rwanda... Boehringer Ingelheim agreed last month to allow Apotex to use its antiretroviral nevirapine in the combination therapy...